MedPath

OPTIRAY 300

OPTIRAY 300

Dormant
DIN Number

02034492

Drug Class

Human

Market Date

Mar 3, 1998

Company
HC

LIEBEL-FLARSHEIM COMPANY LLC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02034492
AIG Number0131317003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AB07 IOVERSOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravascular
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IOVERSOLActive
Strength: 64 % / W/V
Monograph: IOVERSOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.